Pharmacokinetics of intracameral voriconazole injection

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 5, 2009, Pages 2156-2157

  Shen, Ying Cheng ^a,b   Wang, Mei Yen ^c   Wang, Chun Yuan ^a,d   Tsai, Tsun Chung ^c   Tsai, Hin Yeung ^a,d   Lee, Hsin Nung ^a   Wei, Li Chen ^a,b  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b OVERSEAS CHINESE INSTITUTE OF TECHNOLOGY   (Taiwan)

^c TUNGHAI UNIVERSITY   (Taiwan)

^d HUNGKUANG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

VORICONAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS HUMOR; ARTICLE; DRUG ELIMINATION; DRUG HALF LIFE; ENDOPHTHALMITIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; VITREOUS BODY;

ANIMALS; ANTIFUNGAL AGENTS; AQUEOUS HUMOR; HALF-LIFE; INJECTIONS; PYRIMIDINES; RABBITS; TRIAZOLES; VITREOUS BODY;

EID: 66149106652     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01125-08     Document Type: Article

References (13)

1. Abel, R., Jr., and G. L. Boyle. 1976. Dissecting ocular tissue for intraocular drug studies. Investig. Ophthalmol. 15:216-219.
2. Gao, H., M. Pennesi, K. Shah, X. Qiao, S. M. Hariprasad, W. F. Mieler, S. M. Wu, and E. R. Holz. 2004. Intravitreal voriconazole: an electroretinographic and histopathologic study. Arch. Ophthalmol. 122:1687-1692. (Pubitemid 39473415)
3. George, D., P. Miniter, and V. T. Andriole. 1996. Efficacy of UK-109496, a new azole antifungal agent, in an experimental model of invasive aspergillosis. Antimicrob. Agents Chemother. 40:86-91. (Pubitemid 26020748)
4. Lehmann, O. J., J. P. Thompson, L. O. White, M. F. Keys, and M. J. Campbell. 1997. Half-life of intracameral gentamicin after phacoemulsification. J. Cataract Refract. Surg. 23:883-888. (Pubitemid 27375304)
5. Mayers, M., D. Rush, A. Madu, M. Motyl, and M. H. Miller. 1991. Pharmacokinetics of amikacin and chloramphenical in the aqueous humor of rabbits. Antimicrob. Agents Chemother. 35:1791-1798.
6. Meredith, T. A. 1977. Antibiotics and antifungals, p. 363-385. In T. J. Zimmerman (ed.), Textbook of ocular pharmacology. Lippincott-Raven Publishers, Philadelphia, PA.
7. Murphy, C. C., S. Nicholson, S. A. Quah, M. Batterbury, T. Neal, and S. B. Kaye. 2007. Pharmacokinetics of vancomycin following intracameral bolus injection in patients undergoing phacoemulsification cataract surgery. Br. J. Ophthalmol. 91:1350-1353. (Pubitemid 47492872)
8. Oh, C., B. A. Saville, Y. L. Cheng, and D. S. Rootman. 1995. A compartment model for the pharmacokinetics of cyclosporine in rabbits. Pharm. Res. 12:433-437.
9. Perfect, J. R., K. A. Marr, T. J. Walsh, R. N. Greenberg, B. DuPont, J. de la Torre-Cisneros, G. Just-Nübling, H. T. Schlamm, I. Lutsar, A. Espinel-Ingroff, and E. Johnson. 2003. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin. Infect. Dis. 36:1122-1131. (Pubitemid 36549632)
10. Purkins, L., N. Wood, K. Greenhalgh, M. D. Eve, S. D. Oliver, and D. Nichols. 2003. The pharmacokinetics and safety of intravenous voriconazole-a novel wide-spectrum antifungal agent. Br. J. Clin. Pharmacol. 56(Suppl. 1):2-9. (Pubitemid 37491727)
11. Shen, Y. C., M. Y. Wang, C. Y. Wang, T. C. Tsai, H. Y. Tsai, Y. F. Lee, and L. C. Wei. 2007. Clearance of intravitreal voriconazole. Investig. Ophthalmol. Vis. Sci. 48:2238-2241.
12. Thiel, M. A., A. S. Zinkemagel, J. Burhenne, C. Kaufmann, and W. E. Haefeli. 2007. Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis. Antimicrob. Agents Chemother. 51:239-244. (Pubitemid 46047712)
13. Vemulakonda, G. A., S. M. Hariprasad, W. F. Mieler, R. A. Prince, G. K. Shah, and R. N. Van Gelder. 2008. Aqueous and vitreous concentrations following topical administration of 1% voriconazole in humans. Arch. Ophthalmol. 126:18-22.